Table 3.
Maturation rates of ovulated GV oocytes resulting from mice treated with 7.5 mg CLZ 4 h pre-hCG and 2 h post-hCG (Group III)
| Group | GV |
MI |
MII |
|||
|---|---|---|---|---|---|---|
| Control | Treated | Control | Treated | Control | Treated | |
| Maturation stages at ovulation | 0.0 (133) | 91.6 (120) | 0.8a (133) | 8.4b (120) | 99.2a (133) | 0.0 (120) |
| IVM for 10 h | – | 0.0 (126) | – | 1.6a (126) | – | 98.4a (126) |
| IVOM for 106 h | – | 0.0 (160) | – | 5.0b (160) | – | 95.0a (160) |
Data are presented as percent (total number of oocytes). Values with different superscripts are significantly different (P < 0.03) within each oocyte maturation stage of germinal vesicle (GV), metaphase I (MI), or metaphase II (MII). Groups of mice of 7–8 were used for each experiment.
IVM: in vitro maturation; IVOM: in vivo oocyte maturation.